Eupraxia Pharmaceuticals Inc.

TSX:EPRX.TO

Biotechnology

Healthcare
$8.86 +2.49%

+$0.22 today

Market cap
$595.76M
Beta
1.48
P/E (TTM)
-8.6
EPS (TTM)
-$0.74
52W Low $5.82High $12.86

Volume 0.16M

Average 0.05M

EPRX.TO Tax Payables

Taxes owed to authorities that have not yet been paid.

Eupraxia Pharmaceuticals Inc.TSX: EPRX.TO

Tax Payables · Q1 FY2026 · quarter ended Mar 2026

Tax payables remains negative

Q1 FY2026 tax payables was $0, compared with $0 a year earlier.

Context

  • Tax payables amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
  • Tax payables increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
Year agoMar 2025
$0— since
Tax Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Tax Payables history

Mixed currencies · from the balance sheet

Latest · FY2025
0 USD
Year-over-year change
—

Tax Payables vs competitors

How EPRX.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so tax payables is compared through growth and share of total assets rather than absolute size.
  • Tax payables amounts to 0.0% of total assets for EPRX.TO, versus a peer median of 0.0%.
EPRX.TO Competitors
Tax Payables for EPRX.TO and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
WEED.TOCanopy Growth CorporationMar 2026CA$14.4M CAD+10.2%+35.9%1.3%
EPRX.TOEupraxia Pharmaceuticals Inc.Mar 2026$0 USD——0.0%
FRX.TOFennec Pharmaceuticals Inc.Mar 2026$0 USD——0.0%
PRN.TOProfound Medical Corp.Mar 2026$0 USD——0.0%
DR.TOMedical Facilities CorporationMar 2026$0 USD-100.0%—0.0%
TSND.TOTerrAscend Corp.Mar 2026$0 USD-100.0%—0.0%
OGI.TOOrganiGram Holdings Inc.Mar 2026CA$0 CAD——0.0%
HBP.TOHelix BioPharma Corp.Apr 2026CA$0 CAD——0.0%
Peer median (excluding EPRX.TO) —-100.0%+35.9%0.0%

Competitors are the stored peer set for EPRX.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

Mixed currencies
Metric
FY2021
Dec 2021 · CAD
FY2022
Dec 2022 · CAD
FY2023
Dec 2023 · USD
FY2024
Dec 2024 · USD
FY2025
Dec 2025 · USD
Cash & Equivalents20.89M24.74M19.2M33.1M80.42M
Short-term Investments9.01M0000
Net Receivables337.03K121.51K190.61K228.87K673K
Inventory00000
Other Current Assets151.14K10900(7.02K)
Total Current Assets30.6M25.18M19.8M34.44M84.94M
Property, Plant & Equipment (Net)589.07K695.48K452.97K424.92K985.33K
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets31.37K3.37K6.85K80.76K64.22K
Total Non-current Assets620.44K698.85K459.82K505.68K1.05M
Total Assets31.22M25.88M20.12M34.94M85.99M
Account Payables00000
Short-term Debt74.44K107.53K10.37M71.82K78.31K
Tax Payables0036.16K00
Deferred Revenue003.06K00
Other Current Liabilities1.4M1.55M2.73M(1.5M)1.43M
Total Current Liabilities2.27M4.14M19.23M4.46M5.62M
Long-term Debt9.26M10.3M000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities29.71K0000
Total Non-current Liabilities9.4M10.37M0075.77K
Total Liabilities11.67M14.51M19.23M4.46M5.69M
Common Stock80.71M92.34M69.96M116.36M195.05M
Retained Earnings(74.19M)(97.45M)(79.43M)(131M)(169.27M)
Accumulated OCI00(2.7M)(5.98M)(2.04M)
Other Stockholders Equity00662.23K1.82M0
Minority Interest(833.84K)(1.49M)(1.32M)(1.57M)(1.59M)
Total Equity19.55M11.36M892.33K31.84M80.3M
Total Debt9.49M10.55M10.45M71.86K154.08K
Net Debt(11.4M)(14.19M)(8.83M)(33.03M)(80.26M)

Eupraxia Pharmaceuticals Inc.

TSX:EPRX.TO

Intrinsic Alpha fair value

Locked

Current Price

$8.86

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.